1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis

European Radiology

Volumn 23, Issue 12, 2013, Pages 3379-3392

  Bellenberg, Barbara ^a   Busch, Martin ^b   Trampe, Nadine ^a   Gold, Ralf ^a   Chan, Andrew ^a   Lukas, Carsten ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Cervical cord lesions; MR imaging; MR spectroscopy; Multiple sclerosis; Spinal cord

Indexed keywords

CONTRAST MEDIUM; CREATININE; MAGNETOM SYMPHONY; N ACETYLASPARTIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CERVICAL SPINAL CORD INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPINAL CORD ATROPHY;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CERVICAL VERTEBRAE; CREATINE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SPINAL CORD; YOUNG ADULT;

EID: 84890570397     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2942-7     Document Type: Article

References (37)

1. O'Riordan JI, Losseff NA, Phatouros C et al (1998) Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry 64:353-357
2. Kidd D, Thorpe JW, Thompson AJ et al (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43:2632-2637
3. Bot JC, Blezer EL, Kamphorst W et al (2004) The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 233:531-540
4. Bonek R, Orlicka K, Maciejek Z (2007) Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course. Neurol Neurochir Pol 41:229-233
5. Bot JC, Barkhof F, Polman CH et al (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226-233
6. Coret F, Bosca I, Landete L et al (2010) Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis. Mult Scler 16:935-941
7. Qiu W, Raven S, James I et al (2011) Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study. J Neurol Sci 300:114-119
8. Nijeholt GJ, Bergers E, Kamphorst W et al (2001) Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124:154-166
9. Larsson HB, Christiansen P, Jensen M et al (1991) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 22:23-31
10. Sajja BR, Wolinsky JS, Narayana PA (2009) Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 19:45-58
11. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131
12. Mahad DJ, Ziabreva I, Campbell G et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161-1174
13. Ciccarelli O, Altmann DR, McLean MA et al (2010) Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology 74:721-727
14. Kendi AT, Tan FU, Kendi M, Yilmaz S, Huvaj S, Tellioglu S (2004) MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46:764-769
15. Blamire AM, Cader S, Lee M, Palace J, Matthews PM (2007) Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 58:880-885
16. Ciccarelli O, Toosy AT, De Stefano N, Wheeler-Kingshott CA, Miller DH, Thompson AJ (2010) Assessing neuronal metabolism in vivo by modeling imaging measures. J Neurosci 30:15030-15033
17. Ciccarelli O, Wheeler-Kingshott CA et al (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 130:2220-2231
18. Marliani AF, Clementi V, Albini Riccioli L et al (2010) Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 31:180-184
19. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
20. Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 5:244-250
21. Natt O, Bezkorovaynyy V, Michaelis T, Frahm J (2005) Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med 53:3-8
22. Busch M, Liebenrodt K, Gottfried S et al (2005) Influence of brain tumors on the MR spectra of healthy brain tissue. Magn Reson Med 65:18-27
23. Weiland E (2004) Automatische Quantifizierung von Metabolitenkonzentrationen in in-vivo Spektren [doctoral thesis]; http://elib.suub.uni-bremen.de/publications/dissertations/E-Diss1066-Weiland.pdf
24. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J (1993) Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187:219-227
25. Hoult D (1976) The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 24:71-85
26. Van der Klink JJ (2001) The NMR reciprocity theorem for arbitrary probe geometry. J Magn Reson 148:147-154
27. Gasparovic C, Song T, Devier D et al (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55:1219-1226
28. Lukas C, Bellenberg B, Hahn HK et al (2009) Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy. Ther Adv Neurol Disord 2:42-49
29. Bergers E, Bot JC, De Groot CJ et al (2002) Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 59:1766-1771
30. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38:901-909
31. Caramanos Z, Narayanan S, Arnold DL (2005) 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 128:2483-2506
32. Davie CA, Hawkins CP, Barker GJ et al (1993) Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 341:630-631
33. Barker B (2009) Clinical MR spectroscopy, 1st edn. Cambridge University Press, Cambridge
34. Edwards SG, Gong QY, Liu C et al (1999) Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122:291-301
35. Aboul-Enein F, Krssak M, Hoftberger R, Prayer D, Kristoferitsch W (2010) Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. PLoS One 5:e11625
36. Sbardella E, Tomassini V, Stromillo ML et al (2011) Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 17:1432-1440
37. Zackowski KM, Smith SA, Reich DS et al (2009) Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain 132:1200-1209